medroxyprogesterone has been researched along with Osteoporosis, Postmenopausal in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 17 (47.22) | 18.2507 |
| 2000's | 16 (44.44) | 29.6817 |
| 2010's | 1 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, H; Kim, J; Kim, JG; Kim, JH; Ku, SY; Suh, CS | 1 |
| Haapalahti, J; Heikkinen, J; Timonen, U; Vaheri, R | 1 |
| Barnes, S; Boris, ME; Jackson, GS; Martin, BR; McCabe, GP; McCabe, LD; Nolan, JR; Peacock, M; Reinwald, S; Weaver, CM | 1 |
| Liu, J; Wang, Y; Wu, Y; Xing, S; Xu, R; Zhang, Z | 1 |
| Montgomery Rice, V | 1 |
| Armamento-Villareal, R; Civitelli, R; Cohen, S; Dotson, M; Hanes, P; Hauser, J; Hildebolt, CF; Kardaris, EE; Muckerman, J; Pilgram, TK; Shrout, MK; Vannier, MW; Yokoyama-Crothers, N | 1 |
| Morishige, K; Murata, Y; Ohmichi, M; Sawada, K; Tasaka, K; Yamamoto, T | 1 |
| Higashiyama, T; Ikeda, A; Sakai, M; Ueki, M; Ushiroyama, T | 1 |
| Liu, JL | 1 |
| Adachi, JD; Muller, ME; Webber, CE | 1 |
| Cornuz, J; Lamy, O; Wirthner, D | 1 |
| Greenspan, SL; Parker, RA; Resnick, NM | 1 |
| Cho, BY; Kim, SW; Kim, SY; Lee, HK; Park, DJ; Park, KS; Shin, CS | 1 |
| Hayakawa, J; Isobe, A; Mabuchi, S; Morishige, K; Murata, Y; Nishio, Y; Ohmichi, M; Sakata, M; Sasaki, H; Sawada, K; Tasaka, K; Yamamoto, T | 1 |
| Bilgen, T; Cetin, Z; Keser, I; Luleci, G; Simsek, M; Taskin, O | 1 |
| Barengolts, EI; Lathon, PV; Lindh, FG | 1 |
| Boldrini, S; Cini, L; Cristallini, S; Fedeli, L; Filipponi, P; Massoni, C; Palumbo, R; Pedetti, M | 1 |
| Cantatore, FP; Carrozzo, M; Ingrosso, AM; Lacanna, R; Loverro, G; Sassanelli, E; Selvaggi, L | 1 |
| Albisetti, W; Barbacini, P; Brincat, M; Crossignani, PG; Meschia, M | 1 |
| Hart, LL; Yun, S | 1 |
| Barengolts, EI; Kouznetsova, T; Kukreja, SC; Lathon, P; Odvina, C; Segalene, A; Unterman, TG | 1 |
| Bagur, A; Ghiringhelli, G; Mautalen, C; Vega, E; Wittich, A | 1 |
| Honjo, S; Ibuki, Y; Kagami, I; Miyamoto, S; Mizunuma, H; Okano, H; Soda, M; Tokizawa, T | 1 |
| Balske, A; Chilvers, CE; Christiansen, C; Daley, M; Hosking, D; McClung, M; Ravn, P; Ross, P; Thompson, D; Wasnich, R; Yates, AJ | 1 |
| Davies, KM; Dowd, RM; Heaney, RP; Recker, RR | 1 |
| Druckmann, R; Thijssen, JH | 1 |
| Jordan, VC | 1 |
| Grotowski, W; Halerz-Nowakowska, B; Warenik-Szymankiewicz, A; Wiza, M | 1 |
| Han, ZH | 1 |
| Johnson, BE; Lukert, BP; Robinson, RG | 1 |
| Caplan, RH; Hodgson, SF; Judd, HL; Kotowicz, MA; Lane, AW; Lufkin, EG; O'Fallon, WM; Riggs, BL; Wahner, HW | 1 |
| Buxton, BH; Ling, FW; McNeeley, SG; Schinfeld, JS; Stovall, TG | 1 |
| Heikkinen, J; Kurttila-Matero, E; Kyllönen, E; Takala, T; Väänänen, HK; Vuori, J | 1 |
| Christiansen, C; Marslew, U; Riis, BJ | 1 |
| Dören, M; Montag, M; Schneider, HP | 1 |
| Lindsay, R | 1 |
6 review(s) available for medroxyprogesterone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Hormone replacement therapy: optimising the dose and route of administration.
Topics: Administration, Cutaneous; Adult; Aged; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hot Flashes; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic | 2002 |
[Preventing of postmenopausal osteoporosis by hormone replacement therapy? Is the risk acceptable?].
Topics: Age Factors; Aged; Alzheimer Disease; Breast Neoplasms; Cardiovascular Diseases; Climacteric; Colonic Neoplasms; Endometrial Neoplasms; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hysterectomy; Medroxyprogesterone; Meta-Analysis as Topic; Middle Aged; Multivariate Analysis; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Placebos; Prognosis; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Risk; Risk Factors; Socioeconomic Factors; Time Factors | 2004 |
Medroxyprogesterone in osteoporosis.
Topics: Female; Humans; Medroxyprogesterone; Osteoporosis, Postmenopausal | 1993 |
Quantitative assessment of bone mineral density during estrogen replacement therapy.
Topics: Absorptiometry, Photon; Age Factors; Bone Density; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Spine; Tomography, X-Ray Computed | 1999 |
Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing.
Topics: Aged; Breast Neoplasms; Cholesterol; Coronary Disease; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Incidence; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2001 |
Estrogens in prevention and treatment of osteoporosis.
Topics: Aged; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy | 1989 |
19 trial(s) available for medroxyprogesterone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
A 10-year follow-up of the effect of continuous-combined hormone replacement therapy and its discontinuation on bone in postmenopausal women.
Topics: Bone and Bones; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Osteoporosis, Postmenopausal | 2008 |
Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.
Topics: Aged; Analysis of Variance; Bone Density Conservation Agents; Bone Resorption; Calcium; Calcium Radioisotopes; Cotyledon; Cross-Over Studies; Dietary Supplements; Estradiol; Etidronic Acid; Female; Genistein; Glycine max; Humans; Isoflavones; Linear Models; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Pueraria; Risedronic Acid; Single-Blind Method; Treatment Outcome; Trifolium | 2009 |
[Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
Topics: Alkaline Phosphatase; Animals; Body Weight; Bone Density; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Horses; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Progesterone Congeners; Time Factors; Treatment Outcome | 2002 |
The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy.
Topics: Absorptiometry, Photon; Alveolar Bone Loss; Bone Density; Bone Regeneration; Estrogen Replacement Therapy; Estrogens; Female; Femur; Humans; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Radiography, Bitewing | 2002 |
Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition.
Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Middle Aged; Minerals; Osteoporosis, Postmenopausal; Prospective Studies; Radius | 2003 |
The effect of hormone replacement on physical performance in community-dwelling elderly women.
Topics: Accidental Falls; Activities of Daily Living; Aged; Alendronate; Bone Density Conservation Agents; Boston; Calcium; Cognition; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Motor Activity; Osteoporosis, Postmenopausal; Postural Balance; Psychomotor Performance; Treatment Failure; Vitamin D; Walking | 2005 |
Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Alendronate; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Collagen; Collagen Type I; Estrogens; Female; Femur Neck; Humans; Korea; Longitudinal Studies; Medroxyprogesterone; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Spine; Time Factors | 2005 |
Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Calcium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Predictive Value of Tests; Radius; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Cyclical clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Adult; Analysis of Variance; Biomarkers; Bone Density; Bone Development; Clodronic Acid; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Skin Absorption | 1995 |
Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Bone and Bones; Bone Remodeling; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Interleukin-2; Interleukin-6; Medroxyprogesterone; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone | 1995 |
A clinical trial on the effects of a combination of elcatonin (carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women.
Topics: Administration, Oral; Analysis of Variance; Biomarkers; Bone Density; Calcitonin; Drug Synergism; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Menopause; Osteoporosis, Postmenopausal; Spine | 1993 |
Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study.
Topics: Bone Density; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1997 |
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
Topics: Alendronate; Bone Density; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Humans; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Pelvic Bones; Postmenopause; Progesterone Congeners | 1998 |
The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.
Topics: Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Density; Calcium; Creatinine; Dietary Supplements; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxyproline; Medroxyprogesterone; Osteocalcin; Osteoporosis, Postmenopausal; Vitamin D | 1999 |
[Clinical evaluation of Divina in treatment of hormonal disturbances in women].
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Glucose Tolerance Test; Humans; Kidney; Lipid Metabolism; Liver; Medroxyprogesterone; Menopause; Menstruation Disturbances; Middle Aged; Osteoporosis, Postmenopausal | 2001 |
Treatment of postmenopausal osteoporosis with transdermal estrogen.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Bone Density; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Spinal Fractures | 1992 |
Prevention of osteoporosis by medroxyprogesterone acetate in postmenopausal women.
Topics: Adult; Bone Density; Calcium; Drug Evaluation; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal | 1991 |
Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Topics: Absorptiometry, Photon; Bone Density; Calcium; Climacteric; Desogestrel; Drug Therapy, Combination; Estradiol; Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners | 1991 |
[Prospective perimenopausal estrogen-progestin substitution therapies for the prevention of osteoporosis].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Prospective Studies | 1989 |
11 other study(ies) available for medroxyprogesterone and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Polymorphisms in period genes and bone response to hormone therapy in postmenopausal Korean women.
Topics: Bone Density; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur Neck; Genotype; Humans; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Osteoprotegerin; Period Circadian Proteins; Polymorphism, Genetic; Postmenopause; RANK Ligand; Republic of Korea | 2016 |
Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Diphosphonates; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Etidronic Acid; Female; Hormones; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal | 2003 |
Prevention of postmenopausal bone loss with exchange for short-term HRT for 1alpha-hydroxycholecalciferol.
Topics: Absorptiometry, Photon; Administration, Oral; Amino Acids; Bone Density; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxycholecalciferols; Lumbar Vertebrae; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal | 2003 |
[Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy].
Topics: Aged; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Progesterone Congeners | 2003 |
Effects of hormone replacement therapy on bone mineral density in Turkish patients with or without COL1A1 Sp1 binding site polymorphism.
Topics: Absorptiometry, Photon; Bone Density; Case-Control Studies; Collagen Type I; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Sp1 Transcription Factor; Turkey; White People | 2008 |
Progesterone antagonist RU 486 has bone-sparing effects in ovariectomized rats.
Topics: Analysis of Variance; Animals; Bone Density; Bone Resorption; Drug Interactions; Drug Therapy, Combination; Female; Hormone Antagonists; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone; Mifepristone; Osteoporosis, Postmenopausal; Ovariectomy; Progesterone Congeners; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia | 1995 |
Effects of progesterone on serum levels of IGF-1 and on femur IGF-1 mRNA in ovariectomized rats.
Topics: Analysis of Variance; Animals; Blotting, Northern; Bone Development; Disease Models, Animal; Estradiol; Female; Femur; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone; Osteoporosis, Postmenopausal; Ovariectomy; Progesterone Congeners; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic | 1996 |
Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women.
Topics: Adult; Aged; Body Height; Body Weight; Bone Density; Bone Diseases, Metabolic; Densitometry; Drug Tolerance; Estradiol; Estrogen Replacement Therapy; Female; Femur; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Spine | 1996 |
[Postmenopausal osteoporosis and treatment with sex hormones].
Topics: Animals; Calcium; Diethylstilbestrol; Disease Models, Animal; Female; Humans; Magnesium; Medroxyprogesterone; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Wistar | 1992 |
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Prednisone; Retrospective Studies | 1992 |
Moderate exercise does not enhance the positive effect of estrogen on bone mineral density in postmenopausal women.
Topics: Bone Density; Estradiol; Estradiol Congeners; Exercise; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies | 1991 |